JP2020518083A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020518083A5 JP2020518083A5 JP2020502531A JP2020502531A JP2020518083A5 JP 2020518083 A5 JP2020518083 A5 JP 2020518083A5 JP 2020502531 A JP2020502531 A JP 2020502531A JP 2020502531 A JP2020502531 A JP 2020502531A JP 2020518083 A5 JP2020518083 A5 JP 2020518083A5
- Authority
- JP
- Japan
- Prior art keywords
- epitope
- factors
- score
- mutation
- factor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762479320P | 2017-03-31 | 2017-03-31 | |
| US62/479,320 | 2017-03-31 | ||
| PCT/US2018/025597 WO2018183980A2 (en) | 2017-03-31 | 2018-03-31 | Ranking system for immunogenic cancer-specific epitopes |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020518083A JP2020518083A (ja) | 2020-06-18 |
| JP2020518083A5 true JP2020518083A5 (https=) | 2020-07-30 |
| JP7155470B2 JP7155470B2 (ja) | 2022-10-19 |
Family
ID=63676910
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020502531A Active JP7155470B2 (ja) | 2017-03-31 | 2018-03-31 | 免疫原性がん特異的エピトープのためのランク付けシステム |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US11485784B2 (https=) |
| EP (1) | EP3600340A4 (https=) |
| JP (1) | JP7155470B2 (https=) |
| CN (1) | CN110799196B (https=) |
| SG (1) | SG11201907738UA (https=) |
| TW (1) | TWI672503B (https=) |
| WO (1) | WO2018183980A2 (https=) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2970865T3 (es) * | 2015-12-16 | 2024-05-31 | Gritstone Bio Inc | Identificación, fabricación y uso de neoantígenos |
| CA3060569A1 (en) * | 2017-04-19 | 2018-10-25 | Gritstone Oncology, Inc. | Neoantigen identification, manufacture, and use |
| CN111630602A (zh) | 2017-11-22 | 2020-09-04 | 磨石肿瘤生物技术公司 | 减少新抗原的接合表位呈递 |
| BR112021005353A2 (pt) * | 2018-11-21 | 2021-06-15 | Nec Corporation | método e sistema de direcionamento de epitopos para imunoterapia baseada em neoantígeno |
| KR20240091046A (ko) * | 2018-12-21 | 2024-06-21 | 바이오엔테크 유에스 인크. | Hla 클래스 ii-특이적 에피토프 예측 및 cd4+ t 세포 특징화를 위한 방법 및 시스템 |
| EP3931834A1 (en) | 2019-02-28 | 2022-01-05 | Universiteit Antwerpen | Method for determining responsiveness to an epitope |
| WO2020223361A1 (en) * | 2019-04-30 | 2020-11-05 | Memorial Sloan Kettering Cancer Center | System and methods for identification of non-immunogenic epitopes and determining efficacy of epitopes in therapeutic regimens |
| WO2021216787A1 (en) * | 2020-04-21 | 2021-10-28 | Regeneron Pharmaceuticals, Inc. | Methods and systems for analysis of receptor interaction |
| WO2022170067A1 (en) * | 2021-02-05 | 2022-08-11 | Amazon Technologies, Inc. | Ranking neoantigens for personalized cancer vaccine |
| US12518851B2 (en) * | 2021-09-07 | 2026-01-06 | Nec Corporation | Binding peptide generation for MHC class I proteins with deep reinforcement learning for immunotherapy decision making |
| CN118302816A (zh) * | 2021-09-28 | 2024-07-05 | 行动基因(智财)有限公司 | 甲基化生物标记选择装置及方法 |
| WO2025217519A1 (en) * | 2024-04-12 | 2025-10-16 | Foundation Medicine, Inc. | Clonal neoantigen burden as a biomarker of immunotherapy response |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2005301523A (ja) | 2004-04-08 | 2005-10-27 | Celestar Lexico-Sciences Inc | ワクチン候補部分配列予測装置、ワクチン候補部分配列予測方法、ｍｈｃ結合部分配列予測装置、ｍｈｃ結合部分配列予測方法、プログラムおよび記録媒体 |
| WO2013040142A2 (en) * | 2011-09-16 | 2013-03-21 | Iogenetics, Llc | Bioinformatic processes for determination of peptide binding |
| RS61173B1 (sr) | 2013-01-15 | 2021-01-29 | Memorial Sloan Kettering Cancer Center | Imunogeni wt-1 peptidi i postupci za njihovu upotrebu |
| EP2983702A2 (en) | 2013-04-07 | 2016-02-17 | The Broad Institute, Inc. | Compositions and methods for personalized neoplasia vaccines |
| CN113791220A (zh) | 2014-09-10 | 2021-12-14 | 豪夫迈·罗氏有限公司 | 免疫原性突变体肽筛选平台 |
| WO2016128060A1 (en) | 2015-02-12 | 2016-08-18 | Biontech Ag | Predicting t cell epitopes useful for vaccination |
| BR112017022845A2 (pt) | 2015-04-23 | 2018-07-17 | Nantomics, Llc | neoepítopos de câncer |
| CN117467603A (zh) | 2015-04-27 | 2024-01-30 | 癌症研究技术有限公司 | 治疗癌症的方法 |
| EP3323070B1 (en) | 2015-07-14 | 2024-05-08 | Personal Genome Diagnostics Inc. | Neoantigen analysis |
| GB201516047D0 (en) | 2015-09-10 | 2015-10-28 | Cancer Rec Tech Ltd | Method |
| CN107704727B (zh) | 2017-11-03 | 2020-01-31 | 杭州风起智能科技有限公司 | 基于肿瘤新抗原特征值的新抗原活性预测和排序方法 |
-
2018
- 2018-03-31 JP JP2020502531A patent/JP7155470B2/ja active Active
- 2018-03-31 CN CN201880019637.1A patent/CN110799196B/zh active Active
- 2018-03-31 SG SG11201907738UA patent/SG11201907738UA/en unknown
- 2018-03-31 WO PCT/US2018/025597 patent/WO2018183980A2/en not_active Ceased
- 2018-03-31 US US16/497,442 patent/US11485784B2/en active Active
- 2018-03-31 TW TW107111453A patent/TWI672503B/zh active
- 2018-03-31 EP EP18776882.5A patent/EP3600340A4/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020518083A5 (https=) | ||
| Klenerman | The (gradual) rise of memory inflation | |
| Davies et al. | Harnessing bioinformatics to discover new vaccines | |
| JP2021514671A5 (https=) | ||
| Copin et al. | Sequence diversity in the pe_pgrs genes of Mycobacterium tuberculosis is independent of human T cell recognition | |
| US12462898B2 (en) | Method for selecting neoepitopes | |
| TWI672503B (zh) | 致免疫性之癌症特異抗原決定位的排名系統 | |
| JP2019536437A5 (https=) | ||
| JP2020500525A (ja) | 対合が改善されたｔ細胞受容体ｔ細胞 | |
| CA3073812A1 (en) | Neoantigen identification for t-cell therapy | |
| WO2022159176A1 (en) | A deep learning model for predicting tumor-specific neoantigen mhc class i or class ii immunogenicity | |
| WO1998059244A1 (en) | Identification of mhc binding peptides | |
| CN117157713A (zh) | 对用于个性化癌症疫苗的新抗原进行排序 | |
| JP2022502416A5 (https=) | ||
| JP2012516140A5 (https=) | ||
| JP2004512815A5 (https=) | ||
| Kroemer et al. | Can the exome and the immunome converge on the design of efficient cancer vaccines? | |
| JP2013523084A5 (https=) | ||
| Vijayachari et al. | Immunogenicity of a novel enhanced consensus DNA vaccine encoding the leptospiral protein LipL45 | |
| Iurescia et al. | Strategies for improving DNA vaccine performance | |
| CN101724023A (zh) | 结核分枝杆菌抗原限制性表位肽 | |
| Sixsmith et al. | Recombinant Mycobacterium bovis bacillus Calmette-Guerin vectors prime for strong cellular responses to simian immunodeficiency virus gag in rhesus macaques | |
| Arif et al. | Fusion peptide constructs from antigens of M. tuberculosis producing high T-cell mediated immune response | |
| Motamedi et al. | Immunoinformatic evaluation for the development of a potent multi-epitope vaccine against bacterial vaginosis caused by Gardnerella vaginalis | |
| CN119836662A (zh) | 通过经由折叠以处理不同长度的肽的长度来预测新抗原的方法和计算机程序 |